par Messiaen, P.;Cartuyvels, Reinoud;Moreels, Tom;Oude Lashof, Astrid;Hites, Maya 
;Van Der Hilst, Jeroen
Référence Tijdschrift voor geneeskunde, 73, 11, page (688-693)
Publication Publié, 2017
;Van Der Hilst, JeroenRéférence Tijdschrift voor geneeskunde, 73, 11, page (688-693)
Publication Publié, 2017
Article révisé par les pairs
| Résumé : | Patients who take immunosuppressive medications have a higher risk for infectious diseases. Optimally, patients should be protected against infectious diseases before the start of immunosuppressive therapy. At that time, the immune response to vaccination is still optimal and live-Attenuated vaccines are not yet contraindicated. In addition, patients should be screened for several latent infections that can reactivate or aggravate in the immunocompromised state. This article presents an overview of recommended screening, treatment of latent infections and vaccination in patients that are going to start immunosuppressive medication for chronic inflammatory conditions or in the framework for organ transplantation. This is summarized in a practical checklist. |
